Clinical trial · Observational
Effect of PVE on Surgical Outcomes and Long-term Survival in Perihilar Cholangiocarcinoma
Effect of Portal Vein Embolization on Surgical Outcomes and Long-term Survival in Patients With Perihilar Cholangiocarcinoma
NCT06222619CI-TRIAL-00073313completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Portal vein embolization is often recommended to reduce the risk of postoperative liver failure and mortality. In this retrospective cohort study, researchers investigated the effect of portal vein embolization in patients with resectable perihilar cholangiocarcinoma bismuth type III and IV.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Biliary Tract Cancer | Malignant Biliary Tract Neoplasm | ALIAS | 0.90 |
| Portal Vein Embolization | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Potal vein embilization | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Resection without PVE
- description
- Resection of bile duct and associated hemi-liver without portal vein embilzation
- label
- Resection after PVE
- description
- Resection of bile duct and associated hemi-liver after portal vein embilzation
- interventionNames
- Procedure: Potal vein embilization
- label
- No resection after PVE
- description
- No resection of bile duct and associated hemi-liver after portal vein embilzation
- interventionNames
- Procedure: Potal vein embilization
Primary outcomes (1)
- measure
- Overall survival
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. patients with Bismuth type III or IV stricture on radiological examination, including computed tomography (CT) or magnetic resonance cholangiography 2. patients with perihilar cholangiocarcinoma histologically confirmed by surgical resection or forceps biopsy/brush cytology under endoscopic retrograde cholangiopancreatography or through the percutaneous transhepatic biliary drainage tract. Exclusion Criteria: 1. patients with unresectable perihilar cholangiocarcinoma 2. patients who refused treatment 3. patients with other concomitant malignancies.
References
Publications (0)
Data not yet available
No reference posted for this study.